References
- Haefely W et al: Recent advances in the molecular pharmacology of benzodiazepine receptors. Adv Drug Res 14: 165, 1985
- Miller LG et al: Benzodiazepine receptor occupancy “in vivo”: Correlation with brain concentration and pharmacodynamic actions. J Pharmacol Exp Ther 240: 516, 1987
- Greenblatt DJ, Miller LG, Shader RI: Clonazepam pharmacokinetics, brain uptake, and receptor interactions. J Clin Psychiatry 48(Suppl, Oct): 4, 1987
- Arendt RM et al: Determinants of benzodiazepine brain uptake: Lipophilicity versus binding affinity. Psychopharmacology 93: 72, 1987
- Greenblatt DJ, Shader RI, Abernethy DR: Current status of benzodiazepines. N Engl J Med 309: 354, 410, 1983
- Greenblatt DJ, Shader RI: Pharmacokinetics of antianxiety agents. In Psychopharmacology: The Third Generation of Progress. Meitzer HY (Ed). Raven Press, New York, 1987, pp 1377–1386
- Greenblatt DJ et al: Kinetic and dynamic study of intravenous lorazepam: Comparison with intravenous diazepam. J Pharmacol Exp Ther 250: 134, 1989
- Greenblatt DJ et al: Benzodiazepine kinetics: Implications for therapeutics and pharmacogeriatrics. Drug Metab Rev 14: 251, 1983
- Kales A et al: Rebound insomnia and rebound anxiety: A review. Pharmacology 26: 121, 1983
- Greenblatt DJ et al: Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med 317: 722, 1987
- Dietch JT, Jennings RK: Aggressive dyscontrol in patients treated with benzodiazepines. J Clin Psychiatry 49: 184, 1988
- Greenblatt DJ. Shader RI, Harmatz JS: Implications of altered drug disposition in the elderly: Studies of benzodiazepines. J Clin Pharmacol 29: 866, 1989
- Ciraulo DA et al: Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men. J Clin Psychiatry 49: 333, 1988
- Ciraulo DA, Sands BF, Shader RI: Critical review of liability for benzodiazepine abuse among alcoholics. Am J Psychiatry 145: 1501, 1988
- Strom BL: Generic drug substitution revisited. N Engl J Med 316: 1456, 1987
- Miller LG et al: Chronic benzodiazepine administration: I. Tolerance is associated with benzodiazepine receptor downregulation and decreased γ-aminobutyric acidA receptor function. J Pharmacol Exp Ther 246: 170, 1988
- Miller LG et al: Chronic benzodiazepine administration: II. Discontinuation syndrome is associated with upregulation of γ-aminobutyric acidA receptor complex binding and function. Ibid: p 177